| Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials TG Roberts, BH Goulart, L Squitieri, SC Stallings, EF Halpern, ... Jama 292 (17), 2130-2140, 2004 | 373 | 2004 |
| Design and anticipated outcomes of the eMERGE‐PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems LJ Rasmussen‐Torvik, SC Stallings, AS Gordon, B Almoguera, ... Clinical Pharmacology & Therapeutics 96 (4), 482-489, 2014 | 256 | 2014 |
| Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records SL Van Driest, QS Wells, S Stallings, WS Bush, A Gordon, DA Nickerson, ... Jama 315 (1), 47-57, 2016 | 190 | 2016 |
| Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network WS Bush, DR Crosslin, A Owusu‐Obeng, J Wallace, B Almoguera, ... Clinical Pharmacology & Therapeutics 100 (2), 160-169, 2016 | 187 | 2016 |
| The structure of an essential splicing element: stem loop IIa from yeast U2 snRNA SC Stallings, PB Moore Structure 5 (9), 1173-1185, 1997 | 81 | 1997 |
| Genetic variation in the HLA region is associated with susceptibility to herpes zoster DR Crosslin, DS Carrell, A Burt, DS Kim, JG Underwood, DS Hanna, ... Genes & Immunity 16 (1), 1-7, 2015 | 69 | 2015 |
| Trans-ethnic meta-analysis and functional annotation illuminates the genetic architecture of fasting glucose and insulin CT Liu, S Raghavan, N Maruthur, EK Kabagambe, J Hong, MCY Ng, ... The American Journal of Human Genetics 99 (1), 56-75, 2016 | 67 | 2016 |
| Penetrance of Hemochromatosis in HFE Genotypes Resulting in p. Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network CJ Gallego, A Burt, AS Sundaresan, Z Ye, C Shaw, DR Crosslin, ... The American Journal of Human Genetics 97 (4), 512-520, 2015 | 64 | 2015 |
| Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience CR Rohrer Vitek, NS Abul-Husn, JJ Connolly, AL Hartzler, T Kitchner, ... Pharmacogenomics 18 (10), 1013-1025, 2017 | 59 | 2017 |
| A framework to evaluate the economic impact of pharmacogenomics SC Stallings, D Huse, SN Finkelstein, WH Crown, WP Witt, J Maguire, ... Future Medicine Ltd 7 (6), 853-862, 2006 | 48 | 2006 |
| Comparison of the crystal and solution structures of two RNA oligonucleotides JP Rife, SC Stallings, CC Correll, A Dallas, TA Steitz, PB Moore Biophysical journal 76 (1), 65-75, 1999 | 45 | 1999 |
| Chromium, molybdenum, and tungsten zerovalent complexes of the nitrogen chelating ligand 2-(phenylazo) pyridine (2-PAP), including air-stable cis-M (CO) 2 (2-PAP) 2 and M (2-PAP) 3 MN Ackermann, CR Barton, CJ Deodene, EM Specht, SC Keill, ... Inorganic Chemistry 28 (3), 397-403, 1989 | 41 | 1989 |
| A multilevel approach to stakeholder engagement in the formulation of a clinical data research network AP Boyer, AM Fair, YA Joosten, RJ Dolor, NA Williams, L Sherden, ... Medical care 56 (10 Suppl 1), S22, 2018 | 40 | 2018 |
| Direct2Experts: a pilot national network to demonstrate interoperability among research-networking platforms GM Weber, W Barnett, M Conlon, D Eichmann, W Kibbe, ... Journal of the American Medical Informatics Association 18 (Supplement_1 …, 2011 | 37 | 2011 |
| A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments JA Pacheco, LV Rasmussen, RC Kiefer, TR Campion, P Speltz, RJ Carroll, ... Journal of the American Medical Informatics Association 25 (11), 1540-1546, 2018 | 32 | 2018 |
| The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans RJ Ozminkowski, WD Marder, K Hawkins, S Wang, SC Stallings, ... Clinical therapeutics 26 (8), 1341-1354, 2004 | 31 | 2004 |
| Determinants of trustworthiness to conduct medical research: findings from focus groups conducted with racially and ethnically diverse adults DM Griffith, EC Jaeger, EM Bergner, S Stallings, CH Wilkins Journal of General Internal Medicine 35 (10), 2969-2975, 2020 | 30 | 2020 |
| Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network JN Hellwege, S Stallings, ES Torstenson, R Carroll, KM Borthwick, ... Scientific reports 9 (1), 6077, 2019 | 29 | 2019 |
| A taxonomy of impacts on clinical and translational research from community stakeholder engagement SC Stallings, AP Boyer, YA Joosten, LL Novak, A Richmond, YC Vaughn, ... Health Expectations 22 (4), 731-742, 2019 | 28 | 2019 |
| Synthesis and studies of cis-Mo (CO) 2 (L–L′) 2 and Mo (L–L′) 3 complexes of 2-(phenylazo) pyridines (L–L′) and the crystal structures of Mo (CO) 2 (4-methyl-2-(phenylazo … MN Ackermann, SR Kiihne, PA Saunders, CE Barnes, SC Stallings, H Kim, ... Inorganica chimica acta 334, 193-203, 2002 | 24 | 2002 |
